logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Deqi Pharmaceuticals-B (06996.HK) spent 197,700 Hong Kong dollars on September 16 to repurchase 29,500 shares.

date
16/09/2025
Wise Financial News APP announced that Deqi Pharmaceuticals-B (06996.HK) issued a statement, repurchasing 29,500 shares for HKD 197,700 on September 16, 2025.
Latest
1 m ago
The STOXX Europe 600 index continued its decline to a midday low of 0.6%.
1 m ago
The Investment Research Institute of Bank of Wealth Nation: the year-end target range for the S&P 500 Index in 2025 has been raised from the previous forecast of 6300-6500 points to 6600-6800 points.
1 m ago
Scotia Bank Investment Research Institute: The year-end target range for the S&P 500 Index in 2025 has been revised from the previously projected 6300-6500 points to 6600-6800 points.
2 m ago
After rising 3.6% on the previous trading day, the stock price of Tesla has once again increased by 1.2%.
2 m ago
After rising 3.6% on the previous trading day, Tesla's stock price has once again increased by 1.2%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.